Mechanical Ventilation Weaning Protocol in the Coronary Care Unit

NCT ID: NCT00557999

Last Updated: 2007-11-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-03-31

Study Completion Date

2006-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The following objectives were used for comparison: 1) primary objective: reintubation rate during hospitalization; 2) secondary objectives: length of hospitalization at the Coronary Care Unit; time from intubation to start of weaning; time from start of weaning to extubation; time from SBT and extubation; presence of respiratory infection in patients requiring reintubation; mortality of patients requiring reintubation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Once the cause leading to the need of MV was resolved, patients from both groups underwent a daily clinical evaluation in the mornings, to determine whether they were ready for mechanical ventilation weaning, according to the following clinical SBT criteria: 1) Cause of MV: resolution of the cause and abnormalities leading to MV; 2) neurological stability: patient awake, without or with minimal infusion of sedatives/narcotics, with effective cough and Glasgow scale ≥ 9; 3) cardiovascular stability: mean blood pressure (MBP) ≥ 60 mm Hg, without vasopressors or with low vasopressor doses, heart rate (HR) ≤ 140 / min, hemoglobin (Hb) ≥ 8,0 - 10,0 g/L, partial arterial oxygen pressure (PaO2) ≥ 60 mm Hg with fraction of inhaled oxygen (FiO2) ≤ 0.4, oxygenation index (PaO2 / FiO2) ≥ 150 - 300 without significant respiratory acidosis; 4) metabolic stability: temperature \< 37.8° C (armpit) and lack of hydroelectrolytic disorders.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mechanical Ventilation Cardiomyopathy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Cardiology Mechanical ventilation Intensive care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Application of a weaning mechanical ventilation protocol

Group Type OTHER

Application of mechanical ventilation weaning protocol

Intervention Type OTHER

Application protocol for 8 months in experimental group

Control group

Group Type NO_INTERVENTION

Application of mechanical ventilation weaning protocol

Intervention Type OTHER

Application protocol for 8 months in experimental group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Application of mechanical ventilation weaning protocol

Application protocol for 8 months in experimental group

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients hospitalized at the CCU with MV for over 24 hours;
* age over 18 years;
* both genders;
* patients capable of spontaneous ventilation;
* patients with indication for MV weaning.

Exclusion Criteria

* conditions and/or circumstances that might result in difficulty to understand the informed consent (psychiatric disorder, alcohol or drug addiction, mental disability);
* patient denies to sign the informed consent;
* end-stage diseases and
* dependence on mechanical ventilation.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sao Jose do Rio Preto Medical School

OTHER

Sponsor Role collaborator

Hospital de Base

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lilia N Maia, phD

Role: STUDY_DIRECTOR

Sao Jose do Rio Preto Medical School

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C71050P

Identifier Type: -

Identifier Source: secondary_id

CAAE-0009.0.140.000-06

Identifier Type: -

Identifier Source: org_study_id